BP-lowering treatment for patients with type 2 diabetes associated with improved mortality
the ONA take:
According to a new study published in JAMA, researchers have found that blood pressure-lowering treatment in patients with type 2 diabetes is associated with a decreased risk of cardiovascular disease and cardiovascular disease events, coronary heart disease events, and mortality.
For the meta-analysis, researchers identified 40 randomized controlled trials of blood pressure-lowering therapy conducted between 1966 and 2014 that included over 100,000 participants in order to investigate the associations between blood pressure-lowering treatment and cardiovascular disease in patients with type 2 diabetes.
Researchers found that each 10mm Hg lowering of systolic blood pressure was linked with a lower risk of cardiovascular disease events, coronary heart disease events, mortality, stroke, retinopathy, and albuminuria. Researchers did not find a significant difference in associations between blood-pressure lowering treatments and outcomes except for heart failure and stroke.
Results showed that blood pressure reduction below 130mm Hg was associated with a decreased risk of albuminuria, retinopathy, and stroke, but most outcomes had a decreased risk when systolic blood pressure was below 140mm Hg.
The findings supports current guideline recommendations that patients with type 2 diabetes be treated with antihypertensive therapy when their systolic blood pressure is above 140mm Hg.
Blood pressure-lowering treatment in patients with type 2 diabetes is associated with a decreased risk of cardiovascular disease.
- Cholesterol-Lowering Drugs May Prevent Breast Cancer Recurrence
- BBD Regimen Efficacious as First-line Therapy for Myeloma
- Idelalisib Increases Progression-Free Survival in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia
- Trends in Behaviors, Medical Practice Indicate Mortality From Melanoma Will Decline
- Immunotherapy and the Future of Prostate Cancer Treatment
- Survivors Reporting Chronic Neuropathic Pain Struggle to Retain Jobs
- Timing of Chemotherapy Infusion Affects Inflammatory Response to Chemotherapy
- Postoperative Gemcitabine Plus Capecitabine: A New Standard of Care for Pancreatic Cancer
- Blood-Forming Stem Cell Transplants (Fact Sheet)
- Nut Consumption Inversely Associated With Lung Cancer Risk
- Use of Checkpoint Inhibitors in Urothelial Carcinoma
- Chemo + Radiotherapy Efficacious in Muscle-invasive Bladder Cancer
- Elderly with NSCLC Can Tolerate Aggressive Radiation Therapy Treatments
- Colorectal Cancer Risk Higher With Poor Metabolic Health vs Increased Weight
- Best Approach to Infection and Tumor Treatment: Contain or Eliminate?
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|